Form 4 for BRVE Braveheart Bio, Inc.
Accepted 2026-08-10 10:03:28 ET · period of report 2026-08-07 · accession 0001104659-26-093140 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-10 10:03 | 2026-08-07 | BRVE | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% | C - Cnv Deriv | — | +7.42M | 7.42M | New | — |
| D | 2026-08-10 10:03 | 2026-08-07 | BRVE | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% | C - Cnv Deriv | $0.00 | -32.50M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-07 | C | A | 7,420,091 | — | 7,420,091 | D | — | — | (F1) The non-voting Series A preferred stock (the "Preferred Stock") of the Issuer are convertible into shares of Common Stock of the Issuer at the holder's election and have no expiration date. All shares of the Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock. |
| 2 | Derivative | Non-voting Series A preferred stock | 2026-08-07 | C | D | 32,500,000 | $0.00 | 0 | D | — · — to — | 7,420,091 Common Stock | (F1) The non-voting Series A preferred stock (the "Preferred Stock") of the Issuer are convertible into shares of Common Stock of the Issuer at the holder's election and have no expiration date. All shares of the Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock. (F1) The non-voting Series A preferred stock (the "Preferred Stock") of the Issuer are convertible into shares of Common Stock of the Issuer at the holder's election and have no expiration date. All shares of the Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock. (F1) The non-voting Series A preferred stock (the "Preferred Stock") of the Issuer are convertible into shares of Common Stock of the Issuer at the holder's election and have no expiration date. All shares of the Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock. |